Ligand validation:4YL0

BOG: octyl beta-D-glucopyranoside

BOG is a Ligand Of Interest in 4YL0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4YL0_BOG_A_204	24%	70%	0.185	0.815	0.48	0.66	-	-	0	0	100%	1
4YL0_BOG_A_203	5%	71%	0.306	0.715	0.51	0.6	-	-	0	0	100%	1
4AL1_BOG_A_201	17%	70%	0.263	0.84	0.57	0.6	1	-	0	0	100%	1
5T37_BOG_A_204	12%	71%	0.196	0.723	0.49	0.64	-	-	0	0	100%	1
4YL1_BOG_A_205	12%	71%	0.232	0.757	0.48	0.64	-	-	0	0	100%	1
4AL0_BOG_A_1158	11%	62%	0.308	0.856	0.61	0.82	-	-	2	0	85%	0.85
2R4J_BOG_B_700	99%	50%	0.047	0.987	0.82	1.09	1	2	2	0	100%	1
5B5S_BOG_A_301	99%	45%	0.045	0.983	0.92	1.19	1	1	0	0	100%	1
4KRG_BOG_A_503	99%	54%	0.048	0.981	1.11	0.69	2	-	1	0	100%	1
2OXL_BOG_B_101	96%	29%	0.064	0.97	1.1	1.71	2	5	1	1	100%	0.7
7VL5_BOG_A_801	93%	65%	0.072	0.967	0.73	0.63	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.